These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11352760)

  • 21. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima.
    Kodama Y; Ohtaki K; Awa AA; Nakano M; Itoh M; Nakamura N
    Radiat Res; 1999 Nov; 152(5):558-62. PubMed ID: 10521934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
    Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
    Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki.
    Wakabayashi T; Kato H; Ikeda T; Schull WJ
    Radiat Res; 1983 Jan; 93(1):112-46. PubMed ID: 6823504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A long-term cohort study of the atomic-bomb survivors.
    Kodama K; Mabuchi K; Shigematsu I
    J Epidemiol; 1996 Aug; 6(3 Suppl):S95-105. PubMed ID: 8800280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Japanese pediatric and adult atomic bomb survivor dosimetry: potential improvements using the J45 phantom series and modern Monte Carlo transport.
    Griffin KT; Sato T; Funamoto S; Chizhov K; Domal S; Paulbeck C; Bolch W; Cullings HM; Egbert S; Endo A; Hertel N; Lee C
    Radiat Environ Biophys; 2022 Mar; 61(1):73-86. PubMed ID: 34718851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality among atomic bomb survivors.
    Shimizu Y; Kato H; Schull WJ
    J Radiat Res; 1991 Mar; 32 Suppl():212-30. PubMed ID: 1762109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of cancer among atomic bomb survivors.
    Shimizu Y; Kato H; Schull WJ
    J Radiat Res; 1991 Dec; 32 Suppl 2():54-63. PubMed ID: 1823367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term epidemiological studies of atomic bomb survivors in Hiroshima and Nagasaki: study populations, dosimetry and summary of health effects.
    Okubo T
    Radiat Prot Dosimetry; 2012 Oct; 151(4):671-3. PubMed ID: 22908354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosome aberrations and transforming genes in leukemic and non-leukemic patients with a history of atomic bomb exposure.
    Kamada N; Tanaka K; Kasegawa A
    Princess Takamatsu Symp; 1987; 18():125-34. PubMed ID: 3509830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ionizing radiation and cancer risk: evidence from epidemiology.
    Ron E
    Radiat Res; 1998 Nov; 150(5 Suppl):S30-41. PubMed ID: 9806607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki.
    Kerr GD; Egbert SD; Al-Nabulsi I; Bailiff IK; Beck HL; Belukha IG; Cockayne JE; Cullings HM; Eckerman KF; Granovskaya E; Grant EJ; Hoshi M; Kaul DC; Kryuchkov V; Mannis D; Ohtaki M; Otani K; Shinkarev S; Simon SL; Spriggs GD; Stepanenko VF; Stricklin D; Weiss JF; Weitz RL; Woda C; Worthington PR; Yamamoto K; Young RW
    Health Phys; 2015 Dec; 109(6):582-600. PubMed ID: 26509626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytogenetic and molecular changes in leukemia found among atomic bomb survivors.
    Kamada N
    J Radiat Res; 1991 Mar; 32 Suppl():172-9. PubMed ID: 1762103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable chromosome aberrations among A-bomb survivors: an update.
    Stram DO; Sposto R; Preston D; Abrahamson S; Honda T; Awa AA
    Radiat Res; 1993 Oct; 136(1):29-36. PubMed ID: 8210335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological dosimetry of radiation workers at the Sellafield nuclear facility.
    Tucker JD; Tawn EJ; Holdsworth D; Morris S; Langlois R; Ramsey MJ; Kato P; Boice JD; Tarone RE; Jensen RH
    Radiat Res; 1997 Sep; 148(3):216-26. PubMed ID: 9291352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of changes in dosimetry on cancer mortality risk estimates in the atomic bomb survivors.
    Preston DL; Pierce DA
    Radiat Res; 1988 Jun; 114(3):437-66. PubMed ID: 3375435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atomic bomb and leukemia.
    Ichimaru M; Tomonaga M; Amenomori T; Matsuo T
    J Radiat Res; 1991 Dec; 32 Suppl 2():14-9. PubMed ID: 1823351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent chromosome aberrations in the somatic cells of A-bomb survivors, Hiroshima and Nagasaki.
    Awa AA
    J Radiat Res; 1991 Mar; 32 Suppl():265-74. PubMed ID: 1762114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid diseases in atomic bomb survivors exposed in utero.
    Imaizumi M; Ashizawa K; Neriishi K; Akahoshi M; Nakashima E; Usa T; Tominaga T; Hida A; Sera N; Soda M; Fujiwara S; Yamada M; Maeda R; Nagataki S; Eguchi K
    J Clin Endocrinol Metab; 2008 May; 93(5):1641-8. PubMed ID: 18319305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.